Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products using proprietary drug formulation technologies. Eurand develops products using the technology platforms - Bioavailability Enhancement, Controlling Drug Release, Dosage Form (Taste masking/Orally disintegrating tablets) and Drug Targeting. Eurand is a global company with research, development and manufacturing facilities in the US (Dayton, Ohio) and in Europe (Milan and Trieste, Italy; and Paris, France).